Search Results

2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate enhances thrombopoietin-induced megakaryocytic differentiation and plateletogenesis.

• Authors : Kim J; Department of Life Science, Ewha Womans University, Seoul 03760, Korea.; Jin G

Subjects: Blood Platelets/Blood Platelets/Blood Platelets/*cytology ; Blood Platelets/Blood Platelets/Blood Platelets/*drug effects ; Cell Differentiation/Cell Differentiation/Cell Differentiation/*drug effects

• Source: BMB reports [BMB Rep] 2019 Jul; Vol. 52 (7), pp. 434-438.Publisher: Korean Society for Biochemistry and Molecular Biology Country of Publication: Korea (South) NLM ID: 101465334 Publication Model: Print Cited

Record details

US environment agency cuts funding for kids' health studies.

• Authors : Reardon S

Subjects: Organophosphates* ; Pesticides*; Brain

• Source: Nature [Nature] 2019 May; Vol. 569 (7756), pp. 315-317.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Reports from Tabriz University of Medical Sciences Add New Data to Findings in Analytical Chemistry (Combined Health Risk Assessment of Organophosphates Pesticide Residues In Greenhouse Cucumber In the Northwestern of Iran Based On Monte Carlo ...)

• Source: Obesity, Fitness & Wellness Week. April 20, 2024, 3820

Record details

Obscure Cold War nerve agents set to be banned.

• Authors : Stone R; Richard Stone is senior science editor at the Howard Hughes Medical Institute's Tangled Bank Studios in Chevy Chase, Maryland.

Subjects: Chemical Warfare Agents/Chemical Warfare Agents/Chemical Warfare Agents/*legislation & jurisprudence ; Nerve Agents/Nerve Agents/Nerve Agents/*supply & distribution ; Organophosphates/Organophosphates/Organophosphates/*supply & distribution

• Source: Science (New York, N.Y.) [Science] 2019 Oct 25; Vol. 366 (6464), pp. 404-405.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium:

Record details

Chemical biology: Catalytic detoxification.

• Authors : Raushel FM

Subjects: Aryldialkylphosphatase/Aryldialkylphosphatase/Aryldialkylphosphatase/*metabolism ; Organophosphates/Organophosphates/Organophosphates/*metabolism ; Organophosphates/Organophosphates/Organophosphates/*toxicity

• Source: Nature [Nature] 2011 Jan 20; Vol. 469 (7330), pp. 310-1.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Heart attack warning issued.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*adverse effects ; Carbamates/Carbamates/Carbamates/*adverse effects ; Myocardial Infarction/Myocardial Infarction/Myocardial Infarction/*chemically induced

• Source: AIDS patient care and STDs [AIDS Patient Care STDS] 2010 Jan; Vol. 24 (1), pp. 65-6.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9607225 Publication Model: Print Cited Medium: Internet ISSN:

Record details

DNA-catalyzed hydrolysis of DNA phosphodiesters.

• Authors : Fekry MI; Gates KS

Subjects: DNA/DNA/DNA/*chemistry ; Organophosphates/Organophosphates/Organophosphates/*chemistry; Binding Sites

• Source: Nature chemical biology [Nat Chem Biol] 2009 Oct; Vol. 5 (10), pp. 710-1.Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101231976 Publication Model: Print Cited Medium: Internet ISSN:

Record details

[Long-term virus suppression. Expanding therapy options with protease inhibitor].

Subjects: Antiretroviral Therapy, Highly Active*/Antiretroviral Therapy, Highly Active*/Antiretroviral Therapy, Highly Active*/adverse effects ; Viral Load*; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2005 Apr 25; Vol. 147 Spec No 1, pp. 68-9.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Maintaining independence. New protease inhibitor receives drug approval recommendation].

Subjects: Drug Approval/Drug Approval/Drug Approval/*legislation & jurisprudence ; HIV Infections/HIV Infections/HIV Infections/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2004 Apr 26; Vol. 146 Spec No 1, pp. 84-5.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details

[Potent new protease inhibitor. Boostered protease inhibitors--a separate class of drugs].

Subjects: Patient Compliance*; Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*drug therapy ; HIV Protease Inhibitors/HIV Protease Inhibitors/HIV Protease Inhibitors/*administration & dosage

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2003 Apr 28; Vol. 145 Spec No 1, pp. 40-1.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print ISSN: 1438-3276 (Print)

Record details